These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 33095344)
1. Neuromuscular blocking agents in acute respiratory distress syndrome: updated systematic review and meta-analysis of randomized trials. Tarazan N; Alshehri M; Sharif S; Al Duhailib Z; Møller MH; Belley-Cote E; Alshahrani M; Centofanti J; McIntyre L; Baw B; Meade M; Alhazzani W; Intensive Care Med Exp; 2020 Oct; 8(1):61. PubMed ID: 33095344 [TBL] [Abstract][Full Text] [Related]
2. Best evidence in critical care medicine: The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome. Needham CJ; Brindley PG Can J Anaesth; 2012 Jan; 59(1):105-8. PubMed ID: 22042702 [TBL] [Abstract][Full Text] [Related]
3. The effect of neuromuscular blocking agents uses in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. Lyu T; Lee YS; Dhanvijay S; Freebairn R Minerva Anestesiol; 2021 Mar; 87(3):341-350. PubMed ID: 33300324 [TBL] [Abstract][Full Text] [Related]
4. Early neuromuscular blocking agents for adults with acute respiratory distress syndrome: a systematic review, meta-analysis and meta-regression. Shao S; Kang H; Tong Z BMJ Open; 2020 Nov; 10(11):e037737. PubMed ID: 33444180 [TBL] [Abstract][Full Text] [Related]
5. Neuromuscular blockade in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. Ho ATN; Patolia S; Guervilly C J Intensive Care; 2020; 8():12. PubMed ID: 32015880 [TBL] [Abstract][Full Text] [Related]
6. Role of Neuromuscular Blocking Agents in Acute Respiratory Distress Syndrome: An Updated Meta-Analysis of Randomized Controlled Trials. Wei XB; Wang ZH; Liao XL; Guo WX; Qin TH; Wang SH Front Pharmacol; 2019; 10():1637. PubMed ID: 32063852 [TBL] [Abstract][Full Text] [Related]
7. Validation of neuromuscular blocking agent use in acute respiratory distress syndrome: a meta-analysis of randomized trials. Chang W; Sun Q; Peng F; Xie J; Qiu H; Yang Y Crit Care; 2020 Feb; 24(1):54. PubMed ID: 32066488 [TBL] [Abstract][Full Text] [Related]
8. Avoidance versus use of neuromuscular blocking agents for improving conditions during tracheal intubation or direct laryngoscopy in adults and adolescents. Lundstrøm LH; Duez CH; Nørskov AK; Rosenstock CV; Thomsen JL; Møller AM; Strande S; Wetterslev J Cochrane Database Syst Rev; 2017 May; 5(5):CD009237. PubMed ID: 28513831 [TBL] [Abstract][Full Text] [Related]
9. Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. Alhazzani W; Alshahrani M; Jaeschke R; Forel JM; Papazian L; Sevransky J; Meade MO Crit Care; 2013 Mar; 17(2):R43. PubMed ID: 23497608 [TBL] [Abstract][Full Text] [Related]
10. Early spontaneous breathing for acute respiratory distress syndrome in individuals with COVID-19. Hohmann F; Wedekind L; Grundeis F; Dickel S; Frank J; Golinski M; Griesel M; Grimm C; Herchenhahn C; Kramer A; Metzendorf MI; Moerer O; Olbrich N; Thieme V; Vieler A; Fichtner F; Burns J; Laudi S Cochrane Database Syst Rev; 2022 Jun; 6(6):CD015077. PubMed ID: 35767435 [TBL] [Abstract][Full Text] [Related]
11. Neuromuscular blockers in the acute respiratory distress syndrome: A meta-analysis. Hua Y; Ou X; Li Q; Zhu T PLoS One; 2020; 15(1):e0227664. PubMed ID: 31961896 [TBL] [Abstract][Full Text] [Related]
13. Pressure-controlled versus volume-controlled ventilation for acute respiratory failure due to acute lung injury (ALI) or acute respiratory distress syndrome (ARDS). Chacko B; Peter JV; Tharyan P; John G; Jeyaseelan L Cochrane Database Syst Rev; 2015 Jan; 1(1):CD008807. PubMed ID: 25586462 [TBL] [Abstract][Full Text] [Related]
14. Neuromuscular Blocking Agents for ARDS: A Systematic Review and Meta-Analysis. Torbic H; Krishnan S; Harnegie MP; Duggal A Respir Care; 2021 Jan; 66(1):120-128. PubMed ID: 32843506 [TBL] [Abstract][Full Text] [Related]
15. [Systematic evaluation of neuromuscular blocking agents on prognosis of patients with moderate to severe acute respiratory distress syndrome]. Gao ZW; Zhao HM; Sun QS; Sun H; Huang YZ; Zheng P Zhonghua Yi Xue Za Zhi; 2019 Dec; 99(48):3819-3825. PubMed ID: 31874521 [No Abstract] [Full Text] [Related]
16. Sedation and neuromuscular blocking agents in acute respiratory distress syndrome. Bourenne J; Hraiech S; Roch A; Gainnier M; Papazian L; Forel JM Ann Transl Med; 2017 Jul; 5(14):291. PubMed ID: 28828366 [TBL] [Abstract][Full Text] [Related]
17. Neuromuscular blocking agents in patients with acute respiratory distress syndrome: a summary of the current evidence from three randomized controlled trials. Neto AS; Pereira VG; Espósito DC; Damasceno MC; Schultz MJ Ann Intensive Care; 2012 Jul; 2(1):33. PubMed ID: 22835162 [TBL] [Abstract][Full Text] [Related]
18. To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome. Mefford B; Donaldson JC; Bissell BD Ann Pharmacother; 2020 Sep; 54(9):899-906. PubMed ID: 32111121 [No Abstract] [Full Text] [Related]
19. [The effect of neuromuscular blocking agents on prognosis of patients with acute respiratory distress syndrome: a meta analysis]. Wang AT; Gao JL; Li XL; Leng YX; Yao ZY; Zhu X Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Mar; 25(3):149-53. PubMed ID: 23656767 [TBL] [Abstract][Full Text] [Related]